Publications dans lesquelles il/elle collabore avec MANUELA IGARTUA OLAECHEA (13)

2024

  1. Laponite nanoclays for the sustained delivery of therapeutic proteins

    European Journal of Pharmaceutical Sciences, Vol. 201

2022

  1. Clinical progress in MSC-based therapies for the management of severe COVID-19

    Cytokine and Growth Factor Reviews

  2. Human Hair Follicle-Derived Mesenchymal Stromal Cells from the Lower Dermal Sheath as a Competitive Alternative for Immunomodulation

    Biomedicines, Vol. 10, Núm. 2

  3. Hybrid 3D Printed and Electrospun Multi-Scale Hierarchical Polycaprolactone Scaffolds to Induce Bone Differentiation

    Pharmaceutics, Vol. 14, Núm. 12

  4. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 31-40

2021

  1. Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 498-514

  2. Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: Latest trends in isolation, content optimization and delivery avenues

    Pharmaceutics, Vol. 13, Núm. 11

  3. Polycaprolactone hybrid scaffolds combining 3D printing and electrospinning to guide the osteogenic differentiation of MC3T3 preosteoblasts for bone tissue regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 30-32

2020

  1. 3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR

    Biomaterials Science, Vol. 8, Núm. 23, pp. 6741-6753

  2. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges

    Expert Opinion on Drug Delivery, Vol. 17, Núm. 2, pp. 189-200

  3. Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells

    Biomaterials, Vol. 257

2019

  1. Extracellular matrix protein microarray-based biosensor with single cell resolution: Integrin profiling and characterization of cell-biomaterial interactions

    Sensors and Actuators, B: Chemical, Vol. 299

2017

  1. The role of osmolarity adjusting agents in the regulation of encapsulated cell behavior to provide a safer and more predictable delivery of therapeutics

    Drug Delivery, Vol. 24, Núm. 1, pp. 1654